Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT07575984
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT07575984
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Recruiting
Technical summary
Registry record NCT07575984. Randomized; no masking; primary purpose treatment. Start 2025-11-04 (actual); primary completion 2027-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Mexidol
- Intervention (Drug)
- Glycine
- Lead sponsor
- Pharmasoft
Record details
- Record id
cardio:ct-nct07575984- Content hash
38307a89e57a63958e96f497e2c405d9c3cf38a169db388076e3e19b96edac2f